Skip to main content

Advertisement

Log in

IRAK1, a potential therapeutic target for rheumatoid arthritis?

  • Letter to the Editor
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Iguchi T, Ziff M (1986) Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 77:355–361

    Article  PubMed  CAS  Google Scholar 

  2. Zhang H, Pu J, Wang X, Shen L, Zhao G, Zhuang C et al (2012) IRAK1 rs3027898 C/A polymorphism is associated with risk of rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-012-2379-3

    Google Scholar 

  3. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA (2010) A polymorphism in the 3′-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 77:411–413

    Article  PubMed  CAS  Google Scholar 

  4. Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592:265–280

    Article  PubMed  CAS  Google Scholar 

  5. Yokota K, Miyazaki T, Hemmatazad H, Gay RE, Kolling C, Fearon U et al (2011) The pattern-recognition receptor NOD1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. doi:10.1002/art.34318

    Google Scholar 

  6. Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY (2007) Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 108:121–128

    Article  PubMed  CAS  Google Scholar 

  7. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:R101

    Article  PubMed  Google Scholar 

  8. Mosaad YM, Abdelsalam A, El-Bassiony SR (2011) Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis. Int J Immunogenet 38:427–433

    Article  PubMed  CAS  Google Scholar 

  9. Chiang EY, Yu X, Grogan JL (2011) Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. J Immunol 186:1279–1288

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was not supported by any grants.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xie, Q., Wang, SC. & Li, J. IRAK1, a potential therapeutic target for rheumatoid arthritis?. Rheumatol Int 33, 3069–3070 (2013). https://doi.org/10.1007/s00296-012-2579-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2579-x

Keywords

Navigation